Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Risk Stratification for ICDs: The Debate Rages On

Executive Summary

The clinical trials MADIT II and SCD-HeFT definitively proved the benefit of ICDs for preventing the risk of sudden cardiac death and paved the way for reimbursement. But now that the excitement has died down, the confusion has set in. Clinicians aren't entirely sure in which real-world patients to implant devices. The debate about the proper methods of risk stratifying patients for ICD implantation rages on.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

IV002805

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel